Chester Stanley Zygmont III insider trades

Open-market stock purchases and sales by Chester Stanley Zygmont III, Chief Financial Officer at Revelation Biosciences, Inc, from SEC Form 4 filings since Feb 25, 2023.

Recent trades

DateStockTradeValue
Apr 30, 2026REVB Revelation Biosciences, IncSold (not open market)$14.6K
Feb 4, 2026REVB Revelation Biosciences, IncSold (not open market)$21.6K
Jan 8, 2026REVB Revelation Biosciences, IncBought (not open market)$70.3K
Oct 29, 2025REVB Revelation Biosciences, IncBought (not open market)$500K

Companies traded

  • REVB Revelation Biosciences, Inc: other filings, last Apr 30, 2026

Get free alerts when Chester Stanley Zygmont III files a new trade →